Novo Nordisk signed an exclusive agreement with Sciele Pharma to market Prandin (repaglinide).

Pfizer and Nektar Therapeutics released a joint statement today announcing they have resolved all outstanding contractual issues related to Exubera and Nektar's Phase I next generation inhaled insulin (NGI) product.

Pfizer took a $2.8-billion charge for dropping diabetes drug Exubera, but its conduct in exiting the biotech partnership could cost the firm far more.

Pfizer is set to roll out a DTC campaign for smoking-cessation aid Chantix next week, an executive said today.

Pfizer chairman Jeff Kindler said during last weeks Bear Stearns Healthcare Conference that the company expects Lipitor sales to be flat or down up to 5% on last years numbers due to competition from generic Zocor (simvastatin).

A doctor who leaked confidential information about Eli Lillys antipsychotic medication Zyprexa has agreed to terms of a financial settlement with the drugmaker, The New York Times reports.

Spurred on by the approval of Lyrica, the National Fibromyalgia Association is launching an educational campaign to raise awareness of the disorder, which affects an estimated 6 to 10 million Americans.

Three years after the FDA yanked its Wild Thing ads off the air, Pfizer is again taking a playful approach with a Viagra TV spot riffing on the Elvis hit Viva Las Vegas.

The newest indication for Reclast -- postmenopausal osteoporosis -- ups its market potential considerably, analysts said.

Just call it the Energizer Bunny. Despite drawing fire from consumer groups, legislators and other concerned critics wanting to curb it, direct-to-consumer pharmaceutical advertising keeps on going.